Shariq Madha

Shariq Madha

Auto-generated profile, based on publicly available information

Shariq Madha

Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
NMNeil McCarthy
Neil McCarthy
EMElisa Manieri
Elisa Manieri
ESElaine E. Storm
Elaine E. Storm
ASAssieh Saadatpour
Assieh Saadatpour
ALAdrienne M. Luoma
Adrienne M. Luoma
RSRamesh A. Shivdasani
Ramesh A. Shivdasani

1 March 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
KMKazutaka Murata
Kazutaka Murata
UJUnmesh Jadhav
Unmesh Jadhav
SMShariq Madha
Shariq Madha
JEJohan van Es
Johan van Es
JDJustin Dean
Justin Dean
RSRamesh A. Shivdasani
Ramesh A. Shivdasani

5 February 2020 in Molecular Cell
Verified
Journal Article
Closed access
UJUnmesh Jadhav
Unmesh Jadhav
EMElisa Manieri
Elisa Manieri
KNKodandaramireddy Nalapareddy
Kodandaramireddy Nalapareddy
SMShariq Madha
Shariq Madha
SCShaon Chakrabarti
Shaon Chakrabarti
RSRamesh A. Shivdasani
Ramesh A. Shivdasani

1 May 2019 in Molecular Cell
Verified
Journal Article
Closed access
UJUnmesh Jadhav
Unmesh Jadhav
ACAlessia Cavazza
Alessia Cavazza
KBKushal K. Banerjee
Kushal K. Banerjee
HXHuafeng Xie
Huafeng Xie
NONicholas K. O’nEill
Nicholas K. O’nEill
RSRamesh A. Shivdasani
Ramesh A. Shivdasani

2 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PTPei-Yun Tsai
Pei-Yun Tsai
MLMin-Sik Lee
Min-Sik Lee
UJUnmesh Jadhav
Unmesh Jadhav
INInsia Naqvi
Insia Naqvi
SMShariq Madha
Shariq Madha
NKNada Y. Kalaany
Nada Y. Kalaany
Significance: Pancreatic ductal adenocarcinoma (PDA) is a highly lethal malignancy with no effective therapies. PDA aggressiveness partly stems from its ability to grow within a uniquely dense stroma restricting nutrient access. This study demonstrates that PDA clones that survive chronic nutrient deprivation acquire reversible nongenetic adaptations allowing them to switch between metabolic states optimal for growth under nutrient-replete or nutrient-deprived conditions. One contributing factor to this adaptation is mTORC1 activation, which stabilizes glutamine synthetase (GS) necessary for glutamine generation in nutrient-deprived cancer cells. Our findings imply that although total GS levels may not be a prognostic marker for aggressive disease, GS inhibition is of high therapeutic value, as it targets specific cell clusters adapted to nutrient starvation, thus mitigating tumor growth.

26 October 2018 in Genes & Development
Verified
Journal Article
Open access
PDF file
KBKushal K. Banerjee
Kushal K. Banerjee
MSMadhurima Saxena
Madhurima Saxena
NKNamit Kumar
Namit Kumar
LCLei Chen
Lei Chen
ACAlessia Cavazza
Alessia Cavazza
RSRamesh A. Shivdasani
Ramesh A. Shivdasani
After acquiring competence for selected cell fates, embryonic primordia may remain plastic for variable periods before tissue identity is irrevocably determined (commitment). We investigated the chromatin basis for these developmental milestones in mouse endoderm, a tissue with recognizable rostro–caudal patterning and transcription factor (TF)-dependent interim plasticity. Foregut-specific enhancers are as accessible and active in early midgut as in foregut endoderm, and intestinal enhancers and identity are established only after ectopic cis-regulatory elements are decommissioned. Depletion of the intestinal TF CDX2 before this cis element transition stabilizes foregut enhancers, reinforces ectopic transcriptional programs, and hence imposes foregut identities on the midgut. Later in development, as the window of chromatin plasticity elapses, CDX2 depletion weakens intestinal, without strengthening foregut, enhancers. Thus, midgut endoderm is primed for heterologous cell fates, and TFs act on a background of shifting chromatin access to determine intestinal at the expense of foregut identity. Similar principles likely govern other fate commitments.